Defibrillators in heart failure and quality of life [6]

New England Journal of Medicine

Volumn 360, Issue 2, 2009, Pages 188-

  Telerant, Robin M ^a   Boyer, Nathan ^a   Kansagara, Devan ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGORAPHOBIA; ANXIETY; DEFIBRILLATOR; DISEASE EXACERBATION; FEAR; HEART FAILURE; HUMAN; LETTER; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; STATE TRAIT ANXIETY INVENTORY; STRUCTURED INTERVIEW; SYSTOLIC DYSFUNCTION;

EID: 58249104996     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Burke JL, Hallas CN, Clark-Carter D, White D, Connelly D. The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review. Br J Health Psychol 2003;8:165-78.
2. Godemann F, Butter C, Lampe F, et al. Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol 2004;27:321-6.
3. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics 2005;46:451-7.